Ole Molskov Bech

515 total citations
16 papers, 402 citations indexed

About

Ole Molskov Bech is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ole Molskov Bech has authored 16 papers receiving a total of 402 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ole Molskov Bech's work include Diabetes Management and Research (8 papers), Diabetes Treatment and Management (7 papers) and Diabetes and associated disorders (2 papers). Ole Molskov Bech is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes Treatment and Management (7 papers) and Diabetes and associated disorders (2 papers). Ole Molskov Bech collaborates with scholars based in Denmark, China and India. Ole Molskov Bech's co-authors include А. В. Зилов, Pradana Soewondo, Wenying Yang, Philip Home, Rachid Malek, М. В. Шестакова, María Rosario Capeding, Siddharth Shah, Ampaiwan Chuansumrit and León Litwak and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Cardiovascular Research and Diabetes Obesity and Metabolism.

In The Last Decade

Ole Molskov Bech

16 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ole Molskov Bech Denmark 10 247 82 57 34 31 16 402
Samiul Mostafa United Kingdom 14 317 1.3× 83 1.0× 36 0.6× 33 1.0× 38 1.2× 28 442
María L. Méndez Spain 11 93 0.4× 54 0.7× 58 1.0× 21 0.6× 67 2.2× 21 528
Hideo Ayame Japan 4 338 1.4× 94 1.1× 54 0.9× 119 3.5× 39 1.3× 7 549
Margaret Tiktin United States 6 336 1.4× 86 1.0× 64 1.1× 16 0.5× 80 2.6× 7 480
Yang Wen-ying China 5 230 0.9× 53 0.6× 40 0.7× 9 0.3× 24 0.8× 9 329
Mads Faurby Denmark 8 164 0.7× 73 0.9× 48 0.8× 13 0.4× 19 0.6× 31 282
Steven B. Leichter United States 15 317 1.3× 70 0.9× 94 1.6× 18 0.5× 30 1.0× 48 558
Olga Montvida Australia 12 403 1.6× 123 1.5× 97 1.7× 22 0.6× 89 2.9× 31 557
Morsaleh Ganji Iran 9 164 0.7× 40 0.5× 38 0.7× 22 0.6× 54 1.7× 17 359
Anna Glechner Austria 10 117 0.5× 24 0.3× 53 0.9× 74 2.2× 19 0.6× 23 402

Countries citing papers authored by Ole Molskov Bech

Since Specialization
Citations

This map shows the geographic impact of Ole Molskov Bech's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ole Molskov Bech with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ole Molskov Bech more than expected).

Fields of papers citing papers by Ole Molskov Bech

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ole Molskov Bech. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ole Molskov Bech. The network helps show where Ole Molskov Bech may publish in the future.

Co-authorship network of co-authors of Ole Molskov Bech

This figure shows the co-authorship network connecting the top 25 collaborators of Ole Molskov Bech. A scholar is included among the top collaborators of Ole Molskov Bech based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ole Molskov Bech. Ole Molskov Bech is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Khamseh, Mohammad E., et al.. (2013). Safety and Effectiveness of Biphasic Insulin Aspart 30 in Different Age-Groups: A1chieve Sub-Analysis. Diabetes Therapy. 4(2). 347–361. 4 indexed citations
3.
Shah, Siddharth, А. В. Зилов, Rachid Malek, et al.. (2011). Improvements in quality of life associated with insulin analogue therapies in people with type 2 diabetes: Results from the A1chieve observational study. Diabetes Research and Clinical Practice. 94(3). 364–370. 46 indexed citations
4.
5.
Yang, Wenying, et al.. (2010). Observational studies: going beyond the boundaries of randomized controlled trials. Diabetes Research and Clinical Practice. 88. S3–S9. 101 indexed citations
6.
Güler, Serdar, Surendra Kumar Sharma, Chong Hwa Kim, et al.. (2009). Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results. PubMed. 2(2). 23–33. 6 indexed citations
7.
Шестакова, М. В., et al.. (2008). Study design and baseline characteristics of patients in the PRESENT study. Diabetes Research and Clinical Practice. 81. S3–S9. 10 indexed citations
8.
Sharma, Surendra Kumar, Hak Chul Jang, Sami T. Azar, et al.. (2008). Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study. Diabetes Obesity and Metabolism. 10(3). 212–222. 39 indexed citations
9.
Chow, C. C., et al.. (2007). Adding biphasic insulin aspart 30 once or twice daily is more efficacious than optimizing oral antidiabetic treatment in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 9(5). 724–732. 30 indexed citations
10.
Chuansumrit, Ampaiwan, et al.. (2005). Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study. Blood Coagulation & Fibrinolysis. 16(8). 549–555. 46 indexed citations
11.
Roglić, Gojka, David R. Matthews, Richard R. Rubin, & Ole Molskov Bech. (2002). The Oxford International Diabetes Summit: Implications of the DAWN study. Practical Diabetes International. 19(6). 187–192. 10 indexed citations
12.
Andreasen, F., Ulrik Eriksen, Lars Peter Nielsen, et al.. (1993). A comparison of three diuretic regimens in heart failure. European Journal of Clinical Investigation. 23(4). 234–239. 3 indexed citations
13.
Bech, Ole Molskov, et al.. (1990). Effects of long-term coenzyme Q10 and captopril treatment on survival and functional capacity in rats with experimentally induced heart infarction.. Journal of Pharmacology and Experimental Therapeutics. 255(1). 346–350. 12 indexed citations
14.
Bech, Ole Molskov, et al.. (1989). Time course of functional deterioration after coronary artery ligation in rats. Cardiovascular Research. 23(8). 649–654. 10 indexed citations
15.
Bech, Ole Molskov, et al.. (1988). Atrial content and plasma levels of atrial natriuretic peptides in rats with chronic renal failure. Scandinavian Journal of Clinical and Laboratory Investigation. 48(5). 431–439. 1 indexed citations
16.
Bech, Ole Molskov, et al.. (1988). Atrial content and plasma levels of atrial natriuretic peptides in rats with chronic renal failure. Scandinavian Journal of Clinical and Laboratory Investigation. 48(5). 431–439. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samiul Mostafa Breakdown of academic impact, for papers by María L. Méndez Breakdown of academic impact, for papers by Hideo Ayame Breakdown of academic impact, for papers by Margaret Tiktin Breakdown of academic impact, for papers by Yang Wen-ying Breakdown of academic impact, for papers by Mads Faurby Breakdown of academic impact, for papers by Steven B. Leichter Breakdown of academic impact, for papers by Olga Montvida Breakdown of academic impact, for papers by Morsaleh Ganji Breakdown of academic impact, for papers by Anna Glechner
Rankless by CCL
2026